Cargando…

ADMA: A Key Player in the Relationship between Vascular Dysfunction and Inflammation in Atherosclerosis

Atherosclerosis is a chronic cardiovascular disease which increases risk of major cardiovascular events including myocardial infarction and stroke. Elevated plasma concentrations of asymmetric dimethylarginine (ADMA) have long been recognised as a hallmark of cardiovascular disease and are associate...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dowsett, Laura, Higgins, Erin, Alanazi, Sarah, Alshuwayer, Noha A., Leiper, Fiona C., Leiper, James
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7563400/ https://www.ncbi.nlm.nih.gov/pubmed/32962225 http://dx.doi.org/10.3390/jcm9093026

Ejemplares similares

Effects of ADMA upon Gene Expression: An Insight into the Pathophysiological Significance of Raised Plasma ADMA
por: Smith, Caroline L, et al.
Publicado: (2005)

T Cells in Atherosclerosis: Key Players in the Pathogenesis of Vascular Disease
por: Hinkley, Hannah, et al.
Publicado: (2023)

Palliative Treatment for Oral Administration in Cases of Inoperable Malignant Disease
por: Leiper, D. Paterson
Publicado: (1930)

Senescence-induced inflammation: an important player and key therapeutic target in atherosclerosis
por: Stojanović, Stevan D, et al.
Publicado: (2020)

ADMA in Vascular Disease: More than a Marker?
Publicado: (2005)

Asymmetric Dimethylarginine (ADMA) and Endothelial Dysfunction: Implications for Atherogenesis
por: Landim, Maurício Batista Paes, et al.
Publicado: (2009)

Therapeutic Potential of Stem Cell-Derived Extracellular Vesicles on Atherosclerosis-Induced Vascular Dysfunction and Its Key Molecular Players
por: Comariţa, Ioana Karla, et al.
Publicado: (2022)

Meeting Reports
por: Leiper, K. J., et al.
Publicado: (1983)

The Role of Asymmetric Dimethylarginine (ADMA) in Endothelial Dysfunction and Cardiovascular Disease
por: Sibal, Latika, et al.
Publicado: (2010)

ADMA/SDMA in Elderly Subjects with Asymptomatic Carotid Atherosclerosis: Values and Site-Specific Association
por: Riccioni, Graziano, et al.
Publicado: (2014)

Effect of silibinin on endothelial dysfunction and ADMA levels in obese diabetic mice
por: Li Volti, Giovanni, et al.
Publicado: (2011)

Asymmetric Dimethylarginin (ADMA) as a Marker of Endothelial Dysfunction in Primary Aldosteronism
por: Matrozova, Joanna, et al.
Publicado: (2016)

Mitochondrial Dysfunction: The Hidden Player in the Pathogenesis of Atherosclerosis?
por: Ciccarelli, Giovanni, et al.
Publicado: (2023)

Experiences and perceptions of people with headache: a qualitative study
por: Leiper, Deborah A, et al.
Publicado: (2006)

Association of mortality and endothelial dysfunction with serum ADMA level in COVID-19 patients
por: Karacaer, Cengiz, et al.
Publicado: (2022)

A novel DDAH-1 inhibitor improved sepsis-induced impairment in vasoreactivity to noradrenaline in a rat endotoxaemia model
por: Wang, Z, et al.
Publicado: (2011)

A novel DDAH-1 inhibitor improved cardiovascular function in a short-term anesthetized rat model of sepsis
por: Wang, Z, et al.
Publicado: (2011)

Asymmetric dimethylarginine (ADMA), symmetric dimethylarginine (SDMA) and homoarginine (hArg): the ADMA, SDMA and hArg paradoxes
por: Tsikas, Dimitrios, et al.
Publicado: (2018)

A dual role for AMP‐activated protein kinase (AMPK) during neonatal hypoxic–ischaemic brain injury in mice
por: Rousset, Catherine I., et al.
Publicado: (2015)

Vascular stiffening and endothelial dysfunction in atherosclerosis
por: Hooglugt, Aukie, et al.
Publicado: (2022)

Evidence for a protective role for the rs805305 single nucleotide polymorphism of dimethylarginine dimethylaminohydrolase 2 (DDAH2) in septic shock through the regulation of DDAH activity
por: Lambden, Simon, et al.
Publicado: (2018)

Asymmetrical dimethylarginine (ADMA) in critically ill patients: high plasma ADMA concentration is an independent risk factor of ICU mortality
por: Nijveldt, RJ, et al.
Publicado: (2003)

Associations of Biopterins and ADMA with Vascular Function in Peripheral Microcirculation from Patients with Chronic Kidney Disease
por: Arefin, Samsul, et al.
Publicado: (2023)

Non-coding RNAs are key players and promising therapeutic targets in atherosclerosis
por: Yu, Zhun, et al.
Publicado: (2023)

Neopterin Counters Vascular Inflammation and Atherosclerosis
por: Shirai, Remina, et al.
Publicado: (2018)

Vasa Vasorum Angiogenesis: Key Player in the Initiation and Progression of Atherosclerosis and Potential Target for the Treatment of Cardiovascular Disease
por: Sedding, Daniel G., et al.
Publicado: (2018)

Neurovascular dysfunction in vascular dementia, Alzheimer’s and atherosclerosis
por: Shabir, Osman, et al.
Publicado: (2018)

Immunity and inflammation: the neglected key players in congenital heart disease?
por: Wienecke, Laura M., et al.
Publicado: (2021)

Cytokines in atherosclerosis: Key players in all stages of disease and promising therapeutic targets
por: Ramji, Dipak P., et al.
Publicado: (2015)

Dimethylarginine dimethylaminohydrolase-2 deficiency promotes vascular regeneration and attenuates pathological angiogenesis
por: Lange, Clemens, et al.
Publicado: (2016)

Mineralocorticoid Receptors in the Pathophysiology of Vascular Inflammation and Atherosclerosis
por: Moss, Mary E., et al.
Publicado: (2015)

Endothelial-to-Mesenchymal Transition, Vascular Inflammation, and Atherosclerosis
por: Chen, Pei-Yu, et al.
Publicado: (2020)

Platelets, a Key Cell in Inflammation and Atherosclerosis Progression
por: Huilcaman, Ricardo, et al.
Publicado: (2022)

Inflammation and Metabolism in Cancer Cell—Mitochondria Key Player
por: Neagu, Monica, et al.
Publicado: (2019)

Cyclophilin D in Mitochondrial Dysfunction: A Key Player in Neurodegeneration?
por: Coluccino, Gabriele, et al.
Publicado: (2023)

A Novel Role of Irbesartan in Gastroprotection against Indomethacin-Induced Gastric Injury in Rats: Targeting DDAH/ADMA and EGFR/ERK Signaling
por: Shahin, Nancy N., et al.
Publicado: (2018)

Are Short Chain Fatty Acids in Gut Microbiota Defensive Players for Inflammation and Atherosclerosis?
por: Ohira, Hideo, et al.
Publicado: (2017)

The comprehensive assessment of health status in survivors of childhood cancer: application to high-risk acute lymphoblastic leukaemia.
por: Feeny, D., et al.
Publicado: (1993)

Mapping Indigenous land management for threatened species conservation: An Australian case-study
por: Renwick, Anna R., et al.
Publicado: (2017)

Role of vascular smooth muscle cell in the inflammation of atherosclerosis
por: Lim, Soyeon, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_m6b80rljkkdobcn2t0v8ijrggn